Epilepsy Mtoropathies Focal Cortical Dysplasia Leats clinical trials

Explore recruiting epilepsy mtoropathies focal cortical dysplasia leats clinical trials.

Also recruiting in Europe

Epilepsy Mtoropathies Focal Cortical Dysplasia Leats trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Open, randomized, IInd phase clinical study evaluating the safety and efficacy of rapamycin in the treatment of drug-resistant epilepsy in children with rare and ultra rare diseases of the central nervous system associated with the activation of the mTOR pathway : BraimTOR-NEURO

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Epilepsy Mtoropathies Focal Cortical Dysplasia Leats trials by city

Epilepsy Mtoropathies Focal Cortical Dysplasia Leats in Toronto Epilepsy Mtoropathies Focal Cortical Dysplasia Leats in Vancouver Epilepsy Mtoropathies Focal Cortical Dysplasia Leats in Montreal Epilepsy Mtoropathies Focal Cortical Dysplasia Leats in Calgary Epilepsy Mtoropathies Focal Cortical Dysplasia Leats in Edmonton Epilepsy Mtoropathies Focal Cortical Dysplasia Leats in Ottawa Epilepsy Mtoropathies Focal Cortical Dysplasia Leats in Winnipeg Epilepsy Mtoropathies Focal Cortical Dysplasia Leats in Quebec City Epilepsy Mtoropathies Focal Cortical Dysplasia Leats in Hamilton Epilepsy Mtoropathies Focal Cortical Dysplasia Leats in Kitchener Epilepsy Mtoropathies Focal Cortical Dysplasia Leats in London Epilepsy Mtoropathies Focal Cortical Dysplasia Leats in Halifax Epilepsy Mtoropathies Focal Cortical Dysplasia Leats in New York Epilepsy Mtoropathies Focal Cortical Dysplasia Leats in Los Angeles Epilepsy Mtoropathies Focal Cortical Dysplasia Leats in Chicago Epilepsy Mtoropathies Focal Cortical Dysplasia Leats in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease